Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NBTY acquisition

This article was originally published in The Tan Sheet

Executive Summary

Multi-level marketer purchases Synergy Plus dietary supplement line of roughly 300 SKUs on Aug. 7; details of the acquisition were not disclosed. Synergy Plus franchise, which has been available exclusively in health food stores for over 30 years, includes numerous vitamin, mineral and herbal supplements. NBTY notes acquisition is in line with firm's plans to expand its wholesale business with niche products; Knox NutraJoint joint, nail health supplements extended the firm's portfolio in December (1"The Tan Sheet" Dec. 24, 2001, In Brief)...

You may also be interested in...

NBTY Balance Sheet Has Firm Positioned For Acquisitions In FY ’03

NBTY plans to pursue acquisitions more actively after increasing working capital and reducing bank debt over the past fiscal year, President & CFO Harvey Kamil said during a Nov. 6 analysts call

Knox NutraJoint

NBTY's purchase of joint and nail health supplement line from Kraft Foods for approximately $4 mil. expected to close by end of December, firms announce Dec. 19. Purchase includes original NutraJoint and NutraJoint Plus Glucosamine, as well as Knox for Nails. Revenues of acquired products are expected to reach roughly $15 mil. in 2001. NBTY recently announced plans to purchase customer lists, URLs for, from bankrupt HealthCentral (1"The Tan Sheet" Dec. 17, In Brief)...

Cosmetics Europe Talks Microplastic: ECHA Frustrations, ‘Value Judgments’ And International Trade Uncertainty

The European Chemicals Agency's microplastic restriction proposal received committee backing in 2020 without changes sought by the cosmetics industry, which faces €15bn in projected costs and scarce alternatives at present. It may come down to EU Member States to decide whether the ECHA restriction proposal is proportionate in balancing environmental goals and socio-economic impacts.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts